79406165 - BICYCLE

Information

• Trademark
• 79406165

• Source

• Serial Number

  79406165

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto
  • 44 - Medical services

• Filing Date

  May 21, 2024
  7 months ago

• Transaction Date

  December 11, 2024
  16 days ago

• Status Date

  December 10, 2024
  17 days ago

• Status Code

  641

• Current Location

  TMO LAW OFFICE 123

  Employee Name

  BERGER, MAGDALENA

• Law Office Assigned Location Code

  N50

• Owners

  • BicycleTx Limited

Case File Statements

• GS0051: Pharmaceutical products, namely, pharmaceutical preparations for use in oncology for both solid and liquid tumours, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders; pharmaceutical preparations for use as diagnostics, namely, diagnostic preparations for medical use; pharmaceutical preparations for use as clinical imaging agents for positron emission tomography use
• GS0441: Medical services; medical testing; healthcare services; pharmaceutical services; medical consulting services; advisory services relating to pharmaceuticals; consultancy and information services relating to pharmaceuticals; medical services in the field of oncology; medical services in the field of ophthalmology; medical services in the field of neurology; medical services in the field of anti-infectives; medical services in connection with respiratory disease; medical services in connection with cardiovascular disease; medical services in connection with metabolic disease; medical services in connection with the treatment and/or prevention of viral infections; medical services in connection with diagnostics and imaging; medical services in connection with renal disease; medical services in connection with gastrointestinal disease; medical services in connection with muscular skeletal disease; pharmaceutical services in the field of oncology; pharmaceutical services in the field of ophthalmology; pharmaceutical services in the field of neurology; pharmaceutical services in the field of anti-infectives; pharmaceutical services in connection with respiratory disease; pharmaceutical services in connection with cardiovascular disease; pharmaceutical services in connection with metabolic disease; pharmaceutical services in connection with the treatment and/or prevention of viral infections; pharmaceutical services in connection with diagnostics and imaging; pharmaceutical services in connection with renal disease; pharmaceutical services in connection with gastrointestinal disease; pharmaceutical services in connection with muscular skeletal disease; information, consultancy and advisory services relating to the aforesaid
• GS0421: Scientific research; scientific study and research in the field of the development of future human and veterinary medical treatments in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; laboratory research services in the field of oncology for both solid and liquid tumors, metabolic disease, urology and renal disease, cardiovascular, hematology, respiratory, chronic and acute inflammatory disease and auto-immune disorders, gastrointestinal disease, bacterial and viral infectious disease, neurological and psychiatric disorders, diagnostic preparations and clinical imaging agents; providing information, consultancy and advisory services relating to the design, planning and implementation of scientific and clinical research for others

Case File Event Statements

• 10/10/2024 - 2 months ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR

• 10/15/2024 - 2 months ago

  2 - LIMITATION FROM ORIGINAL APPLICATION ENTERED Type: LIMI

• 10/15/2024 - 2 months ago

  3 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 11/26/2024 - a month ago

  7 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 12/10/2024 - 17 days ago

  8 - REFUSAL PROCESSED BY MPU Type: RFRR

• 12/10/2024 - 17 days ago

  9 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 11/25/2024 - a month ago

  6 - NON-FINAL ACTION WRITTEN Type: CNRT

• 10/15/2024 - 2 months ago

  4 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 11/16/2024 - a month ago

  5 - ASSIGNED TO EXAMINER Type: DOCK